Abstract:Background: Hypertension is a major risk factor for renal disease progression. However, the mechanisms by which hypertension aggravates the effects of diabetes on the kidney are incompletely understood. We tested the hypothesis that renovascular hypertension accelerates angiotensin-II-dependent kidney damage and inflammation in the db/db mouse, a model of type II diabetes. Methods: Renovascular hypertension was established in db/db and wild-type control mice through unilateral renal artery stenosis (RAS); the non-stenotic contralateral kidneys evaluated 2, 4 and 6 weeks later. Angiotensin-II infusion (1000 ng/kg/min), unilateral nephrectomy, or both were also performed in db/db mice to discern the contributions of hypertension versus hyperfiltration to development of chronic renal injury in db/db mice with RAS. The effect of blood pressure reduction in db/db mice with RAS was assessed using angiotensin-receptor-blocker (ARB) or hydralazine treatment. Results: Db/db mice with renovascular hypertension developed greater and more prolonged elevation of renin activity than all other groups studied. Stenotic kidneys of db/db mice developed progressive interstitial fibrosis, tubular atrophy, and interstitial inflammation. Contralateral kidneys of wild type mice with RAS showed minimal histopathologic abnormalities, whereas db/db mice with RAS developed severe diffuse mesangial sclerosis, interstitial fibrosis, tubular atrophy, and interstitial inflammation. Db/db mice with Angiotensin II-induced hypertension developed interstitial lesions and albuminuria but not mesangial matrix expansion, while nephrectomized db/db mice exhibited modest mesangial expansion and interstitial fibrosis, but not significant albuminuria. The combination of unilateral nephrectomy and angiotensin II infusion reproduced all the features of the injury albeit in a less severe manner. ARB and hydralazine were equally effective in attenuating the development of mesangial expansion in the contralateral kidneys of db/db mice with RAS. However, only ARB prevented elevation of urinary albumin/creatinine in db/db mice with RAS. Conclusion: Renovascular hypertension superimposed on diabetes exacerbates development of chronic renal disease in db/db mice at least in part through interaction with the renin-angiotensin system. Both ARB and hydralazine were equally effective in reducing systolic blood pressure and in preventing renal injury in the contralateral kidney of db/db mice with renal artery stenosis. ARB but not hydralazine prevented elevation of urinary albumin/creatinine in the db/db RAS model.

[Effects of Angiotensin II Type 1 Receptor Blocker on Islet of Diabetic Db/db Mice].

Angiotensin II receptor blocker provides pancreatic β-cell protection independent of blood pressure lowering in diabetic db/db mice

Beneficial Effects of Candesartan, an Angiotensin II Type 1 Receptor Blocker, on Β-Cell Function and Morphology in Db/db Mice

Effects of an angiotensin Ⅱ type 1 receptor blocker telmisartan on secretory function of β-cell in db/db mice

Candesartan Reduced Advanced Glycation End-Products Accumulation and Diminished Nitro-Oxidative Stress in Type 2 Diabetic KK/Ta Mice

Effects of Angiotensin-Ii Receptor Blockers on Β-Catenin Expression in a Rat Model of Experimental Streptozotocin-Induced Early-Stage of Diabetic Nephropathy

The Effects of Telmisartan on Intra-Islet Microvasculature in Db/db Mice

[The Effects of Endothelin Blockade on Renal Expression of Angiotensin II Type 1 Receptor in Diabetic Hypertensive Rats].

Effects of Telmisartan on the Expression of NADPH Oxidase in the Pancreatic Islet of Db/db Mice

Telmisartan Improves First-Phase Insulin Secretion in Vitro in Db/db Mice

O4‐01‐04: Beneficial Effects of Angiotensin II Receptor Blockers on Metabolic Disorder‐induced Cognitive Impairment

Protective effects and the mechanism of Rosuvastatin on type 2 diabetic rats

#5018 EFFECTS OF CANDESARTAN COMPARED TO LOSARTAN ON INHIBITING MESANGIAL EXPANSION IN DIABETIC MODEL RATS RECEIVING ROSMARINIC ACID

Improved Glucose-Stimulated Insulin Secretion by Selective Intraislet Inhibition of Angiotensin II Type 1 Receptor Expression in Isolated Islets of Db/db Mice

Effects of angiotensin II on morphology and function of islets β-cells in rats

Direct Angiotensin Ii Type 2 Receptor Stimulation Ameliorates Insulin Resistance In Type 2 Diabetes Mice With Ppar Gamma Activation

Ang-(1-7) Improves Islet B Cell Function By Up-Regulating The Activity Of Ang-(1-7)-Mas Axis/Pdx-1

Effect of Irbesartan on Oxidative Stress and Serum Inflammatory Factors in Renal Tissues of Type 2 Diabetic Rats.

Peroxisome proliferator-activated receptor-γ activation with angiotensin II type 1 receptor blockade is pivotal for the prevention of blood-brain barrier impairment and cognitive decline in type 2 diabetic mice.

Combined effect of hyperfiltration and renin angiotensin system activation on development of chronic kidney disease in diabetic db/db mice

Protective Effect of Irbesartan by Inhibiting ANGPTL2 Expression in Diabetic Kidney Disease